Product Information
METFORMIN ER 1,000 MG GASTR-TB is a generic product labeled by Oceanside Pharmaceuticals, priced at $0.8418 per EA under NDC 68682001890. Its NADAC has been published 397 times since Mar 29, 2017.
FDA first approved this application on Jun 3, 2005.
The High Outlier badge above means this manufacturer's average price in the metformin hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1000 mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682001890
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
10/23/2024
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021748FDA Approved
6/3/2005
On Market Since
6/17/2008
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN ER 1,000 MG GASTR-TB has been published 397 times since Mar 29, 2017, and over the history we have for it it has declined 99.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8418 per EA |
|---|---|
| All-time high | $86.4756 (Aug 16, 2017) |
| All-time low | $0.5161 (Apr 17, 2024) |
| Median price | $8.5750 |
| Average price | $15.2864 |
| Largest weekly change | +118.1% (Feb 23, 2022) |
| Weeks tracked | 397 |
| Tracking since | Mar 29, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-62.3%
5Y
-88.3%
All
-99.0%
Last surveyed Oct 30, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
metformin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METFORMIN ER 1,000 MG GASTR-TB?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN ER 1,000 MG GASTR-TB, manufactured by Oceanside Pharmaceuticals, is $0.8418 per EA (NDC 68682001890), effective Oct 30, 2024.
How has the price of METFORMIN ER 1,000 MG GASTR-TB changed over time?
Over the history we have for it, the NADAC for METFORMIN ER 1,000 MG GASTR-TB has declined 99.0%. It has been tracked across 397 weekly CMS publications since Mar 29, 2017.
What are the highest and lowest recorded NADAC prices for METFORMIN ER 1,000 MG GASTR-TB?
Since Mar 29, 2017, the NADAC for METFORMIN ER 1,000 MG GASTR-TB has ranged from a low of $0.5161 (Apr 17, 2024) to a high of $86.4756 (Aug 16, 2017), with a median of $8.5750 per EA.
Are there cheaper alternatives to METFORMIN ER 1,000 MG GASTR-TB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, METFORMIN HCL 1,000 MG TABLET, is $0.0232 per EA — about 97% below METFORMIN ER 1,000 MG GASTR-TB.
Who manufactures METFORMIN ER 1,000 MG GASTR-TB?
METFORMIN ER 1,000 MG GASTR-TB (NDC 68682001890) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.